Jane Street
MYGN icon

Jane Street’s Myriad Genetics MYGN Stock Holding History

Jane Street’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,200
Closed -$195K – 9773
2023
Q4 		$195K Sell
10,200
-10,500
-51% -$182K ﹤0.01% 8239
2023
Q3 		$332K Buy
+20,700
New +$394K ﹤0.01% 6918
2023
Q2 		– Sell
-59,900
Closed -$1.39M – 9255
2023
Q1 		$1.39M Buy
59,900
+48,300
+416% +$981K ﹤0.01% 4424
2022
Q4 		$168K Sell
11,600
-20,900
-64% -$389K ﹤0.01% 7789
2022
Q3 		$620K Buy
32,500
+10,400
+47% +$239K ﹤0.01% 6284
2022
Q2 		$402K Sell
22,100
-16,800
-43% -$349K ﹤0.01% 7124
2022
Q1 		$980K Buy
+38,900
New +$996K ﹤0.01% 6181
2021
Q4 		– Sell
-14,000
Closed -$452K – 10573
2021
Q3 		$452K Sell
14,000
-8,800
-39% -$292K ﹤0.01% 7484
2021
Q2 		$697K Buy
22,800
+11,400
+100% +$329K ﹤0.01% 6602
2021
Q1 		$347K Sell
11,400
-19,000
-63% -$539K ﹤0.01% 7465
2020
Q4 		$601K Buy
30,400
+12,700
+72% +$205K ﹤0.01% 5457
2020
Q3 		$231K Sell
17,700
-5,000
-22% -$63.3K ﹤0.01% 6253
2020
Q2 		$257K Buy
+22,700
New +$322K ﹤0.01% 6058
2020
Q1 		– Sell
-20,700
Closed -$564K – 5746
2019
Q4 		$564K Buy
+20,700
New +$569K ﹤0.01% 3551

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jane Street's MYGN Position: Q2 2026 in Review

Jane Street sold out of Myriad Genetics (MYGN) in Q2 2026, closing a stake of 1,202,531 shares — an estimated $5.41M sold.

Jane Street first reported a position in MYGN in Q4 2013 and held it in 30 quarters. The position peaked at $5.41M in Q1 2026. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • Jane Street reported no remaining Myriad Genetics position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 1,202,531 Myriad Genetics shares in Q2 2026, an estimated $5.41M.
  • Jane Street first reported a position in Myriad Genetics in Q4 2013 and held it in 30 quarters.
  • Jane Street's Myriad Genetics position peaked at $5.41M in Q1 2026.
  • 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.